Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
Price Target
Average
650.00%
Revenue Forecast
Estimate
66.48%
EBIT
Estimate
--41.80%
Net Income
Estimate
33.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Esperion Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ESPR of $12 , with forecasts ranging from
a
low of
$8 to a high of $20 .
ESPR Lowest Price Target
Wall Street Target
8 USD
400.00%
ESPR Average Price Target
Wall Street Target
12 USD
650.00%
ESPR Highest Price Target
Wall Street Target
20 USD
1150.00%
REVENUE FORECAST
Revenue Forecast Chart ESPR
EBIT FORECAST
EBIT Forecast Chart ESPR
NET INCOME FORECAST
Net Income Chart ESPR